Copyright
©The Author(s) 2016.
World J Transplant. Jun 24, 2016; 6(2): 380-388
Published online Jun 24, 2016. doi: 10.5500/wjt.v6.i2.380
Published online Jun 24, 2016. doi: 10.5500/wjt.v6.i2.380
Figure 1 Overall survival.
A: Overall survival from orthotopic heart transplant; B: Overall survival comparing OHT for AL amyloidosis to OHT from 1992 to 2011 for non-amyloid indications; C: Comparison of survival with non OHT subgroups. OHT: Orthotopic heart transplantation; CHF: Congestive heart failure; AL: Immunoglobulin light chain.
- Citation: Grogan M, Gertz M, McCurdy A, Roeker L, Kyle R, Kushwaha S, Daly R, Dearani J, Rodeheffer R, Frantz R, Lacy M, Hayman S, McGregor C, Edwards B, Dispenzieri A. Long term outcomes of cardiac transplant for immunoglobulin light chain amyloidosis: The Mayo Clinic experience. World J Transplant 2016; 6(2): 380-388
- URL: https://www.wjgnet.com/2220-3230/full/v6/i2/380.htm
- DOI: https://dx.doi.org/10.5500/wjt.v6.i2.380